Prulifloxacin

Research use only, not for human use.

Prulifloxacin is a broad-spectrum fluoroquinolone antibiotic. It Inhibits bacterial DNA synthesis by inhibiting the activity of bacterial DNA topoisomerase II and IV.

Prulifloxacin is a broad-spectrum fluoroquinolone antibiotic. It Inhibits bacterial DNA synthesis by inhibiting the activity of bacterial DNA topoisomerase II and IV.(In Vivo):After oral administration of NM441 at a dose of 20 mg/kg to dogs, the peak concentration of NM394 in plasma was 2.39 micrograms/ml, whereas it was 0.63 micrograms/ml for NM394 administered alone. NM441 was as effective as ofloxacin and was twice as effective as ciprofloxacin against systemic infection with Staphylococcus aureus. Against infections with streptococci, NM441 was two to three times as effective as ofloxacin and five times as effective as ciprofloxacin.

——

After oral administration of NM441 at a dose of 20 mg/kg to dogs, the peak concentration of NM394 in plasma was 2.39 micrograms/ml, whereas it was 0.63 micrograms/ml for NM394 administered alone. NM441 was as effective as ofloxacin and was twice as effective as ciprofloxacin against systemic infection with Staphylococcus aureus. Against infections with streptococci, NM441 was two to three times as effective as ofloxacin and five times as effective as ciprofloxacin.

NM441 | AF 3012 | Pruvel

Cell Cycle/DNA Damage

Topoisomerase

Topo II| Topo IV

Infection

Acute exacerbations of chronic bronchitis; Bacterial infections; Pneumonia; Respiratory tract infections; Urinary tract infections

123447-62-1

461.46

C21H20FN3O6S

>98% (HPLC)

DMSO: 15 mg/mL (32.5 mM);Water: Insoluble

CC1Sc2c(C(O)=O)c(=O)c3cc(F)c(cc3n12)N1CCN(Cc2oc(=O)oc2C)CC1

6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-13-dioxol-4-yl)methyl)piperazin-1-yl)-4-oxo-1H4H-[13]thiazeto[32-a]quinoline-3-carboxylic acid

(-20℃)

With Ice Pack

≥ 2 years